Leo Pharma looks for CEO with capital markets experience ahead of IPO

Four months into Jesper Brandgaard's tenure as chairman of the board at Leo Pharma, CEO Catherine Mazzacco is stepping down. Now, the hunt for a new CEO to take the company through an initial public offering process begins.

Chairman of the board at Leo Pharma Jesper Brandgaard. | Photo: PR

Just four months after becoming chairman of the board at Leo Pharma, Jesper Brandgaard has found himself working with the daily activities at the company.

Catherine Mazzacco, who has been President and CEO at the company since August 2019, is on her way out, meaning that Jesper Brandgaard is becoming a "working chairman" while CFO Anders Kronborg steps in as acting CEO.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs